Modulation of circulating angiogenic factors and tumor biology by aerobic training in breast cancer patients receiving neoadjuvant chemotherapy. - Wikidata - awgldk - TriplyDB

Modulation of circulating angiogenic factors and tumor biology by aerobic training in breast cancer patients receiving neoadjuvant chemotherapy.

Modulation of circulating angiogenic factors and tumor biology by aerobic training in breast cancer patients receiving neoadjuvant chemotherapy.

http://www.wikidata.org/entity/Q37238130

about

Exercise in Regulation of Inflammation-Immune Axis Function in Cancer Initiation and Progression Exercise Prevention of Cardiovascular Disease in Breast Cancer Survivors Role of n-3 Polyunsaturated Fatty Acids and Exercise in Breast Cancer Prevention: Identifying Common Targets Concurrent Neoadjuvant Chemoradiotherapy for Siewert II and III Adenocarcinoma at Gastroesophageal Junction Cancer therapy-induced autonomic dysfunction in early breast cancer: implications for aerobic exercise training.Effect of aerobic training on the host systemic milieu in patients with solid tumours: an exploratory correlative study.Exercise training improves heart rate recovery in women with breast cancer.Optitrain: a randomised controlled exercise trial for women with breast cancer undergoing chemotherapy Modulation of murine breast tumor vascularity, hypoxia and chemotherapeutic response by exercise.EXercise to prevent AnthrCycline-based Cardio-Toxicity (EXACT) in individuals with breast or hematological cancers: a feasibility study protocol Can exercise suppress tumour growth in advanced prostate cancer patients with sclerotic bone metastases? A randomised, controlled study protocol examining feasibility, safety and efficacy.Exercise and Aerobic Fitness to Reduce Cancer-Related Cardiovascular Toxicity.Supervised physical exercise improves VO2max, quality of life, and health in early stage breast cancer patients: a randomized controlled trial.Therapeutic properties of aerobic training after a cancer diagnosis: more than a one-trick pony?Meta-analysis of Exercise Training on Vascular Endothelial Function in Cancer Survivors.Exercise-dependent regulation of the tumour microenvironment.Impact of a half marathon on cellular immune system, pro-inflammatory cytokine levels, and recovery behavior of breast cancer patients in the aftercare compared to healthy controls.Expression and clinical significance of serum MMP-7 and PTEN levels in patients with acute myeloid leukemia.

P2860

Q26775189-E2D12070-F26B-4969-91F7-F398F5B5658D Q26785410-4489AE25-160B-459E-8E33-D95E096C7E0C Q28066027-3ABE6B3B-5C23-4F51-90FA-C9BCE5D3266C Q33422992-CBF8C846-B728-40B0-A24D-CBD9D9FDA9F8 Q33978019-92CAD171-97B9-47B9-B961-CAD9671C80B2 Q35678685-A9421C28-300A-4C60-AF72-FADF29843EDC Q35907911-81A8BE60-CFAB-4C1B-9C84-3F9455D0D5C8 Q36272109-55A7124B-9717-4133-BC03-FF3D9699855A Q36770262-FB10B00A-E1E2-4BB9-9754-EBA466048C6D Q37497677-92BAE91B-92C3-4DA0-B84B-23CE9EB6C9CB Q38676999-B3AB1E2C-9C42-4D9E-BE73-576C11C0CDB4 Q38834995-4A1247FE-87FF-4129-B405-0232DCB82F70 Q41465790-F1CA852C-5070-45A5-956B-F856954CCB26 Q42360479-0480520E-DF6D-4B01-A43C-61B778FD62D5 Q49484026-1D860320-356D-4F6D-B4FB-B12074BAC18B Q49875257-76D1DB40-8190-487E-B9D0-3C2F68B7A6C8 Q50741520-BF65C81E-98A9-4198-A3A9-5621AC944D37 Q52725090-278DB6D7-56FF-472E-B204-4FA3E3C2CE5D

P2860

Modulation of circulating angiogenic factors and tumor biology by aerobic training in breast cancer patients receiving neoadjuvant chemotherapy.

http://www.wikidata.org/entity/Q37238130

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 10 July 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Modulation of circulating angi ...... ving neoadjuvant chemotherapy.

@en

Modulation of circulating angi ...... ving neoadjuvant chemotherapy.

@nl

type

label

Modulation of circulating angi ...... ving neoadjuvant chemotherapy.

@en

Modulation of circulating angi ...... ving neoadjuvant chemotherapy.

@nl

prefLabel

Modulation of circulating angi ...... ving neoadjuvant chemotherapy.

@en

Modulation of circulating angi ...... ving neoadjuvant chemotherapy.

@nl

P1433

Q37238130-C8F40FD9-9D92-4795-A35C-1223F2B0EB98

P1476

Q37238130-8155E030-46D0-4FE0-8FFD-DA2C6B64D79C

P2093

Q37238130-07E0E243-F45E-42EC-981F-C836094CFF32

Q37238130-115355EA-223C-43D9-8D7B-76BE11C88DC4

Q37238130-31EBA354-203F-4FEF-BDE6-9A0FF4464CBF

Q37238130-3EC96C65-4199-49D9-A1FF-DF72AE8B674A

Q37238130-566022C2-0305-4BF9-956C-FF051566CBE2

Q37238130-71600A41-0DE1-4723-81E9-A2E85EE4AF9D

Q37238130-80459443-C60A-4DAE-907B-FBC1930FF0B7

Q37238130-810BB72A-423D-4104-90AF-E4CC03B55D3E

Q37238130-A915C1F2-2187-4651-B365-4EC9C534345B

Q37238130-C3A7C83E-3FA8-4257-A5E6-C5F4E10C8FDB

P2860

Q37238130-007E8D1E-AFAC-412C-85CF-944BDB1E77CB

Q37238130-0201EDC4-4A93-4D16-958D-13185A3DF3ED

Q37238130-0362658B-5B4B-43EF-8226-75E542D5408C

Q37238130-05CD305C-8EB1-4442-8989-3A21411C0E54

Q37238130-08353236-4E86-40BE-BD1C-2FCA19DDABED

Q37238130-08421C84-C8BF-417D-9B25-8C1AE4814C4A

Q37238130-0A843C35-E232-4650-8DC6-B164F89D7322

Q37238130-0F4E6011-FE39-4A86-B3EC-834BFF42AE3B

Q37238130-0FC9B49D-DCD7-42DD-86AE-C802515281DD

Q37238130-1BA4C9C8-54F9-40C9-906B-96D8D593E043

P304

Q37238130-883181D3-9AB0-4792-863F-048DC9E3AAFB

P31

Q37238130-6DA6B93F-851E-4F7E-A1F7-08AEDADEA0A7

P356

Q37238130-6C72D1F0-C88A-41F7-AEA2-87543382198F

P433

Q37238130-0D2423C7-351C-4E35-A016-6BFA2DA09F45

P478

Q37238130-12104326-F55B-47B1-9F0E-DAB4261788E0

P50

Q37238130-031E554F-2E32-4A8B-AE01-F50A04FA8D7A

Q37238130-9EC95604-42FA-43C1-A109-805F1DA9E5D6

Q37238130-DDBFCAAF-33FA-45F4-93D4-87913BBE58F0

P577

Q37238130-0748BAA9-CC93-4D9C-94A8-C9D9278A758A

P5875

Q37238130-3F096E3C-A48D-4DA5-8F6D-9849E42A87ED

P698

Q37238130-EE11D554-FBF7-4882-AAB7-7DD26670C188

P921

Q37238130-81C7DECC-B06F-41BD-8937-79A1328F5F1F

P932

Q37238130-5EF5C6D6-86A3-4366-8AF4-6E42A47D7B91

P356

1940-6207.CAPR-12-0416

P1433

Cancer Prevention Research

P1476

Modulation of circulating angi ...... ving neoadjuvant chemotherapy.

@en

P2093

Diane R Fels

http://www.w3.org/2001/XMLSchema#string

Elisabeth Masko

http://www.w3.org/2001/XMLSchema#string

Gretchen Kimmick

http://www.w3.org/2001/XMLSchema#string

Jeffrey Peppercorn

http://www.w3.org/2001/XMLSchema#string

Kimberly L Blackwell

http://www.w3.org/2001/XMLSchema#string

Lee G Wilke

http://www.w3.org/2001/XMLSchema#string

Lee W Jones

http://www.w3.org/2001/XMLSchema#string

Mark W Dewhirst

http://www.w3.org/2001/XMLSchema#string

Miranda West

http://www.w3.org/2001/XMLSchema#string

P Kelly Marcom

http://www.w3.org/2001/XMLSchema#string

P2860

Exercise interventions on health-related quality of life for cancer survivors

Exercise interventions on health-related quality of life for people with cancer during active treatment

VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche

Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis

Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma

Isolation of putative progenitor endothelial cells for angiogenesis

HMG-CoA reductase inhibitor mobilizes bone marrow--derived endothelial progenitor cells

Angiogenesis in skeletal muscle precede improvements in peak oxygen uptake in peripheral artery disease patients

Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agents.

Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers.

P304

925-937

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1940-6207.CAPR-12-0416

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Pamela S. Douglas

Gloria Broadwater

P577

2013-07-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

248396908

http://www.w3.org/2001/XMLSchema#string

P698

23842792

http://www.w3.org/2001/XMLSchema#string

P921

P932

3800005

http://www.w3.org/2001/XMLSchema#string